{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:16:48Z","timestamp":1777393008390,"version":"3.51.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2024,9,24]]},"abstract":"<jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Observational Alzheimer\u2019s disease (AD) cohorts including the Australian, Biomarkers, Imaging and Lifestyle (AIBL) Study have enhanced our understanding of AD. The generalizability of findings from AIBL to the general population has yet to be studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We aimed to compare characteristics of people with AD dementia in AIBL to 1) the general population of older Australians using pharmacological treatment for AD dementia, and to 2) the general population of older Australians who self-reported a diagnosis of dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Descriptive study comparing people aged 65 years of over (1) in AIBL that had a diagnosis of AD dementia, (2) dispensed with pharmacological treatment for AD in Australia in 2021 linked to the Australian census in 2021 (refer to as PBS\/census), (3) self-reported a diagnosis of dementia in the 2021 Australian census (refer to as dementia\/census). Baseline characteristics included age, sex, highest education attainment, primary language, and medical co-morbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Participants in AIBL were younger, had more years of education, and had a lower culturally and linguistically diverse (CALD) population compared to the PBS\/census cohort and dementia\/census cohort (mean age\u00b1standard deviation \u2013 AIBL 79\u00b17 years, PBS\/census 81\u00b17,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a&lt;\u200a0.001, dementia\/census 83\u00b18,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a&lt;\u200a0.001; greater than 12 years of education AIBL 40%, PBS\/census 35%,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a=\u200a0.020, dementia\/census 29%,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a&lt;\u200a0.001; CALD \u2013 AIBL 3%, PBS\/census 20%,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a&lt;\u200a0.001, dementia\/census 22%,\n                      <jats:italic>p<\/jats:italic>\n                      \u200a&lt;\u200a0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that care should be taken regarding the generalizability of AIBL in CALD populations and the interpretation of results on the natural history of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jad-240241","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T11:13:52Z","timestamp":1725016432000},"page":"737-749","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["A Comparison of an Australian Observational Longitudinal Alzheimer\u2019s Disease Cohort to Community-Based Australian Data"],"prefix":"10.1177","volume":"101","author":[{"given":"Andrew Liem Hieu","family":"Huynh","sequence":"first","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"},{"name":"Department of Aged Care, Austin Health, Heidelberg, VIC, Australia"},{"name":"Department of Medicine, Austin Health, University of Melbourne, Heidelberg, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Ma","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Ling Clare","family":"Low","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weisi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Fowler","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin C.K.","family":"Tan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Pan","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia"},{"name":"Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the AIBL Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3233\/ADR-210005"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70090-0"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70044-9"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00277-x"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12293"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12640"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610209009405"},{"key":"e_1_3_6_10_2","unstructured":"Department of Health and Aged Care. Memantine Pharmaceutical Benefits Scheme (PBS) https:\/\/www.pbs.gov.au\/medicine\/item\/1956Y-2492E-2513G-9306T (2023)."},{"key":"e_1_3_6_11_2","unstructured":"Department of Health and Aged Care. Donepezil Pharmaceutical Benefits Scheme (PBS) https:\/\/www.pbs.gov.au\/medicine\/item\/11922l-11924n-2479l-2532g-8495d-8496e (2023)."},{"key":"e_1_3_6_12_2","unstructured":"Department of Health and Aged Care. Rivastigmine Pharmaceutical Benefits Scheme (PBS) https:\/\/www.pbs.gov.au\/medicine\/item\/10538P-10541T-11901J-11903L-11904M-11912Y-11916E-11923M-11925P-2475G-2477J-2493F-2494G-2526Y-2551G-8497F-8498G-8499H-8500J-9161E-9162F (2023)."},{"key":"e_1_3_6_13_2","unstructured":"Department of Health and Aged Care. Galantamine Pharmaceutical Benefits Scheme (PBS) https:\/\/www.pbs.gov.au\/medicine\/item\/11899G-11917F-11918G-2463P-2531F-2537M-8770N-8771P-8772Q (2023)."},{"key":"e_1_3_6_14_2","first-page":"709","article-title":"Geriatric Depression Scale","volume":"24","author":"Yesavage JA","year":"1988","unstructured":"YesavageJA. Geriatric Depression Scale. Psychopharmacol Bull 1988; 24: 709\u2013711.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/09540261.2013.860890"},{"key":"e_1_3_6_16_2","unstructured":"Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians https:\/\/www.abs.gov.au\/statistics\/people\/aboriginal-and-torres-strait-islander-peoples\/estimates-aboriginal-and-torres-strait-islander-australians\/30-june-2021 (2021)."},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013295"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102527"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.03.007"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000320508.11013.4f"},{"key":"e_1_3_6_21_2","first-page":"e12222","article-title":"Including ethnic minorities in dementia research: Recommendations from a scoping review","volume":"8","author":"Brijnath B","year":"2022","unstructured":"BrijnathB, CroyS, SabatesJ, et al. Including ethnic minorities in dementia research: Recommendations from a scoping review. Alzheimers Dement 2022; 8: e12222.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50353"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301706"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-016-0301-4"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12823"},{"key":"e_1_3_6_26_2","first-page":"e12102","article-title":"Evaluating the Alzheimer\u2019s disease data landscape","volume":"6","author":"Birkenbihl C","year":"2020","unstructured":"BirkenbihlC, SalimiY, Domingo-FernandezD, et al. Evaluating the Alzheimer\u2019s disease data landscape. Alzheimers Dement 2020; 6: e12102.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011146"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65273-w"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.04.001"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51838"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807"},{"key":"e_1_3_6_33_2","unstructured":"HardingSL L. McDonald P. Morrison P. TrewinD. Walters S.. Report on the quality of 2021 Census data https:\/\/www.abs.gov.au\/census\/about-census\/census-statistical-independent-assurancepanel-report (2022)."},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01741-2"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-240241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-240241","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-240241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:59:04Z","timestamp":1777370344000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-240241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9,24]]}},"alternative-id":["10.3233\/JAD-240241"],"URL":"https:\/\/doi.org\/10.3233\/jad-240241","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}